Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-23-005910
Filing Date
2023-09-05
Accepted
2023-09-05 14:05:35
Documents
33
Period of Report
2023-07-31

Document Format Files

Seq Description Document Type Size
1 10-Q fussbrands_10q.htm   iXBRL 10-Q 572885
2 EXHIBIT 31.1 fussbrands_ex31-1.htm EX-31.1 15311
3 EXHIBIT 32.1 fussbrands_ex32-1.htm EX-32.1 6761
  Complete submission text file 0001829126-23-005910.txt   2217370

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE fbds-20230731.xsd EX-101.SCH 14865
5 XBRL CALCULATION FILE fbds-20230731_cal.xml EX-101.CAL 24340
6 XBRL DEFINITION FILE fbds-20230731_def.xml EX-101.DEF 50917
7 XBRL LABEL FILE fbds-20230731_lab.xml EX-101.LAB 133905
8 XBRL PRESENTATION FILE fbds-20230731_pre.xml EX-101.PRE 112204
27 EXTRACTED XBRL INSTANCE DOCUMENT fussbrands_10q_htm.xml XML 208203
Mailing Address 80 BROAD STREET 5TH FLOOR NEW YORK NY 10004
Business Address 80 BROAD STREET 5TH FLOOR NEW YORK NY 10004 917-720-3366
Fuss Brands Corp. (Filer) CIK: 0000926844 (see all company filings)

EIN.: 841273503 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-34808 | Film No.: 231235130
SIC: 2834 Pharmaceutical Preparations